Molecular Biology Reports

, Volume 46, Issue 1, pp 991–995 | Cite as

Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma

  • Shiva Sadeghpour
  • Saeid GhorbianEmail author
Original Article


Esophageal squamous cell carcinoma (ESCC) is the seventh most common cause of cancer death in worldwide. LncRNA-BANCR is a long non-coding RNA (lncRNA), which has made new windows in cancer investigations. The aim of this survey was to determine the lncRNA-BANCR gene expression changes in patients with ESCC. In case-control investigation was performed on 150 formalin fixed-paraffin embedded tissues (75 cancerous and 75 non-cancerous tissues) of ESCC patients. The lncRNA-BANCR gene expression alteration was assessed by Real-Time PCR technique. Our findings revealed that lncRNA-BANCR gene expression was increased significantly in tumor tissues compared with the non-cancerous tissues (p = 0.0025). In addition, lncRNA-BANCR gene expression changes was positively associated with the lymph node metastasis (p = 0.013), tumor differentiation (p = 0.019) and tumor stage (p = 0.017). Our results suggest a possible role of lncRNA-BANCR in proliferation of esophageal tissues and may be considered as a potential prognostic value for ESCC metastasis.


LncRNA-BANCR gene Squamous cell carcinoma Non-coding RNA ESCC 



The present study is the result of a master’s degree dissertation, which was approved at the Ahar Branch, Islamic Azad University, Iran. The authors would like to thank all of the people who collaborated in this study.


This study has no any funded.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interests.

Research involving human participants or animals

This article does not describe any studies on human participants or animals performed by any of the authors.


  1. 1.
    Li Y, Zhu CL, Nie CJ, Li JC, Zeng TT, Zhou J et al (2013) Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma. PLoS ONE 8(4):e60027CrossRefGoogle Scholar
  2. 2.
    Lin DC, Wang MR, Koeffler HP (2017) Genomic and epigenomic aberrations in esophageal squamous cell carcinoma and implications for patients. Gastroenterology 154:374–389CrossRefGoogle Scholar
  3. 3.
    Ghorbian S, Ardekani AM (2012) Non-invasive detection of esophageal cancer using genetic changes in circulating cell-free DNA. Avicenna J Med Biotechnol 4(1):3–13Google Scholar
  4. 4.
    Luo J, Wang W, Tang Y, Zhou D, Gao Y, Zhang Q et al (2017) mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes. J Cancer 8(4):646–656CrossRefGoogle Scholar
  5. 5.
    Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N et al (2017) Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget 8(23):37740–37750CrossRefGoogle Scholar
  6. 6.
    Shigaki H, Baba Y, Watanabe M, Iwagami S, Miyake K, Ishimoto T et al (2012) LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history. Ann Surg Oncol 19(13):4238–4243CrossRefGoogle Scholar
  7. 7.
    Talukdar FR, Ghosh SK, Laskar RS, Mondal R (2013) Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India. PLoS ONE 8(4):e60996CrossRefGoogle Scholar
  8. 8.
    Aalijahan H, Ghorbian S (2019) Long non-coding RNAs and cervical cancer. Exp Mol Pathol 106:7–16CrossRefGoogle Scholar
  9. 9.
    Yang JZ, Ji AF, Wang JS, Chen ZY, Wen SW (2014) Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis. Asian Pac J Cancer Prev 15(9):3921–3925CrossRefGoogle Scholar
  10. 10.
    Ma S, Bao JYJ, Kwan PS, Chan YP, Tong CM, Fu L et al (2012) Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology 143(3):675–686CrossRefGoogle Scholar
  11. 11.
    Liu Z, Yang T, Xu Z, Cao X (2016) Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Biomed Pharmacother 82:406–412CrossRefGoogle Scholar
  12. 12.
    Wang D, Wang D, Wang N, Long Z, Ren X (2016) Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway. Cell Physiol Biochem 40(3–4):644–656CrossRefGoogle Scholar
  13. 13.
    Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37–40CrossRefGoogle Scholar
  14. 14.
    Su M, Xiao Y, Ma J, Cao D, Zhou Y, Wang H et al (2018) Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications. J Hematol Oncol 11:118CrossRefGoogle Scholar
  15. 15.
    Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C et al (2017) Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis. Cell Death Dis 8(6):e2888CrossRefGoogle Scholar
  16. 16.
    Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li Y et al (2017) Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2. Oncotarget 8(44):76015–76028Google Scholar
  17. 17.
    Liu B, Pan CF, Yao GL, Wei K, Xia Y, Chen YJ (2018) The long non-coding RNA AK001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma. Cancer Cell Int 18:38CrossRefGoogle Scholar
  18. 18.
    Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li SQ et al (2014) Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biol 35(8):7743–7754CrossRefGoogle Scholar
  19. 19.
    Sohda M, Kuwano H (2017) Current status and future prospects for Esophageal Cancer treatment. Ann Thorac Cardiovasc Surg 23(1):1–11CrossRefGoogle Scholar
  20. 20.
    Cai B, Zheng Y, Ma S, Xing Q, Wang X, Yang B, Yin G, Guan F (2017) BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR 204. Int J Oncol 51(6):1941–1951CrossRefGoogle Scholar
  21. 21.
    Li L, Zhang L, Zhang Y, Zhou F (2015) Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. Biomed Pharmacother 72:109–112CrossRefGoogle Scholar
  22. 22.
    Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS, Ji QH (2017) BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Oncotarget 8(1):238–247Google Scholar
  23. 23.
    Kutty RK, Samuel W, Duncan T, Postnikova O, Jaworski C, Nagineni CN et al (2017) Proinflammatory cytokine interferon-γ increases the expression of BANCR, a long non-coding RNA, in retinal pigment epithelial cells. Cytokine 104:147–150CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Department of Molecular Genetics, Ahar BranchIslamic Azad UniversityAharIran

Personalised recommendations